openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 2
Dr. Reddy's Amlodipine Besylate and Benazepril Hydrochloride 5 mg*/20 mg, 500 Capsules, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepalli - 502 325 INDIA, NDC 55111-340-05
Foreign material or chemical contaminationreason.foreign_material_chemical_contamination · v1.0.0
Foreign Tablets
Labeling or packagingreason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall
Adulterated Presence of Foreign Tablets: Dr. Reddy's Laboratories has received complaints of mislabeled bottles of Amlodipine Besylate and Benazepril Hydrochloride Capsules and Ciprofloxacin Tablets.
Code information
C201293 Exp Date 08/2013
Distribution pattern
Nationwide and Puerto Rico
drug · product 2 of 2
Dr. Reddy's Ciprofloxacin Tablets, USP 500 mg*, 500 Tablets, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepalli - 502 325 INDIA, NDC 55111-127-05
Foreign material or chemical contaminationreason.foreign_material_chemical_contamination · v1.0.0
Foreign Tablets
Labeling or packagingreason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall
Adulterated Presence of Foreign Tablets: Dr. Reddy's Laboratories has received complaints of mislabeled bottles of Amlodipine Besylate and Benazepril Hydrochloride Capsules and Ciprofloxacin Tablets
